Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pelvic Organ Prolapse
Open-data reference.
41 US clinical trials · 8 currently recruiting
Active & Recent Trials
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
Ethicon
NCT04829175
The AccelERate Trial
NICHD Pelvic Floor Disorders Network
NCT07218016
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
Medstar Health Research Institute
NCT06634459
SORE Study: Sitz Baths After Urogynecologic Reconstruction
Yale University
NCT07215780
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
University of Alabama at Birmingham
NCT07008898
Centered Surgery - Preoperative Counseling and Patient Satisfaction
The Cleveland Clinic
NCT07471464
GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study
Ethicon
NCT04829058
Pessary Experience Study
University of Virginia
NCT06021769
EASE: The Materna Prep Pivotal Study
Materna Medical
NCT03973281
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
Brigham and Women's Hospital
NCT03522961
SCP vs HUSLS for Pelvic Organ Prolapse Repair
Loma Linda University
NCT02800512
Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse
Mayo Clinic
NCT04179955
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
University of Alabama at Birmingham
NCT05731284
Clinical Investigation of the da Vinci Surgical System
Intuitive Surgical
NCT05682742
Vaginal Orthosis Use After Vaginal Reconstructive Surgery
University of Alabama at Birmingham
NCT05812859
Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy
Atlantic Health System
NCT02248935
The Extended Operations And Pelvic Muscle Training In The Management Of Apical Support Loss Study
NICHD Pelvic Floor Disorders Network
NCT01166373
Race, Ethnicity, Socioeconomic Status and Prolapse-rElated Decisional ConflicT
Women and Infants Hospital of Rhode Island
NCT04977141
Predictors of Recovery Expectancy
Indiana University
NCT04274491
Validation of Transvaginal Tactile Imaging
Artann Laboratories
NCT01491334
Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery
Halina M Zyczynski, MD
NCT02727322
Colpocleisis for Advanced Pelvic Organ Prolapse
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT00271037
Predictors of Post Operative Morbidity in Older Women With Pelvic Organ Prolapse
University of Pennsylvania
NCT01967446
Pelvic Floor Disorder Assessment of Knowledge and Symptoms: an Educational Model in Spanish-Speaking Women
Johns Hopkins University
NCT04829721
Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery
Yale University
NCT03539107
Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery
Joseph Kowalski
NCT05658887
Caregiver Support and Post-operative Convalescence
Icahn School of Medicine at Mount Sinai
NCT04897061
The Purpose of This Study is to Look at Pelvic Support Problems, Also Commonly Known as Pelvic Organ Prolapse
University of Oklahoma
NCT00964197
Impact of Level III Support Procedure on Enlarged Genital Hiatus After Minimally Invasive Sacrocolpopexy
University of Pittsburgh
NCT04480671
Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies
Loyola University
NCT01124916
Feasibility Study of the Reia Vaginal Pessary
Reia
NCT04508335
Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study
Coloplast A/S
NCT01541748
Pudendal Nerve Block in Vaginal Surgery
MetroHealth Medical Center
NCT04198714
Lidocaine for Pessary Check Pain Reduction
University of South Florida
NCT05493735
Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery
The Cleveland Clinic
NCT03048682
Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP
TriHealth
NCT02073734
EVeRLAST 2-Year Follow-Up
Duke University
NCT05542836
Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use
Mayo Clinic
NCT02680145
Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial
University of North Carolina, Chapel Hill
NCT02367235
Perineorrhaphy Outcomes Related to Body Imagery
University of New Mexi
NCT02548858
Advanced Biomarker Assessment in Pelvic Organ Prolapse
Mayo Clinic
NCT03642054
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Pelvic Organ Prolapse Trial Landscape
ClinicalTrials.gov lists 41 US studies indexed under Pelvic Organ Prolapse, and 8 of those are currently open to recruitment — roughly 20% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Pelvic Organ Prolapse shows 4 late-stage studies (Phase 3 and Phase 4 combined) alongside 0 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Pelvic Organ Prolapse is led by Mayo Clinic with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 41 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Pelvic Organ Prolapse?
PlainTrial tracks 41 US clinical trials for Pelvic Organ Prolapse, of which 8 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Pelvic Organ Prolapse?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.